Back to results
CompletedPhase 2

Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant

NCT00795769

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Seattle, Washington, United States

View on ClinicalTrials.gov
Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant — TrialFind